CAXTON CORP

PrivateCIK: 1388551
Location

PRINCETON, NJ

πŸ“‹ What this filing means

CAXTON CORP filed this quarterly 13F‑HR report disclosing 7 equity positions with a total reported market value of $34.65M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.

7
Positions
$34.65M
Total AUM (reported)
14.08M
Total Shares

Allocation by class

TOTAL AUM$34.65M7 positions
COM$32.04M92.5%
COM NEW$2.61M7.5%

Portfolio Concentration

Top 396.4%4–103.6%TOP 10100.0%0%100%
Top 3$33.42M96.4%
4–10$1.23M3.6%

Top 3 weight

96.4%

Top 10 weight

100.0%

Voting Authority Distribution

Total shares with voting rights: 14.08M

Sole

Full voting authority

14.08M

shares

% of voting shares100.0%
Shared

Joint voting authority

0.00

shares

% of voting shares0.0%
None

No voting authority

0.00

shares

% of voting shares0.0%

Investment Discretion (by position count)

Sole7
Shared0
Other0
Dominant voting typeSole Β· 100.0% of voting shares
Institutional Holdings7
Rows:

SAVARA INC

SOLE
COM
Shares4.98M
TypeSH
Market value$16.03M
46.25%
Sole
4.98M
Shared
0.00
None
0.00

XERIS BIOPHARMA HOLDINGS INC

SOLE
COM
Shares5.64M
TypeSH
Market value$14.78M
42.66%
Sole
5.64M
Shared
0.00
None
0.00

REZOLUTE INC

SOLE
COM NEW
Shares1.32M
TypeSH
Market value$2.61M
7.54%
Sole
1.32M
Shared
0.00
None
0.00

MOLECULAR TEMPLATES INC

SOLE
COM
Shares2.05M
TypeSH
Market value$985.4K
2.84%
Sole
2.05M
Shared
0.00
None
0.00

COMPASS THERAPEUTICS INC

SOLE
COM
Shares43.47K
TypeSH
Market value$138.2K
0.40%
Sole
43.47K
Shared
0.00
None
0.00

ALLAKOS INC

SOLE
COM
Shares17.73K
TypeSH
Market value$77.3K
0.22%
Sole
17.73K
Shared
0.00
None
0.00

ELEVATION ONCOLOGY INC

SOLE
COM
Shares21.73K
TypeSH
Market value$33.0K
0.10%
Sole
21.73K
Shared
0.00
None
0.00
CAXTON CORP 13F Holdings β€” 7 Positions | Finecho